Long‐Term Metabolic Consequences of Switching from Protease Inhibitors to Efavirenz in Therapy for Human Immunodeficiency Virus–Infected Patients with Lipoatrophy

Vicente Estrada, Manuel Serrano‐Ríos, Noemí González Pérez de Villar et al.|Clinical Infectious Diseases|2002

Cited by 48